Summary--In normal mouse Leydig cells, steady state levels of mRNA of CYPIlA, 31~-hydroxysteroid dehydrogenase A 5-> A4-isomerase (38 HSD), and CYP17 are differentially regulated. There is high basal expression of 3/~HSD and CYPI IA mRNA, while expression of CYPI7 mRNA is absolutely dependent on cAMP stimulation, cAMP is required for maximal expression of all three enzymes. The expression of CYP11A in normal mouse Leydig cells is repressed by glucocorticoids. Glucocorticoids also repress both basal and cAMP-induced expression of 3]~HSD mRNA, but do not repress the synthesis or mRNA levels of CYPI7. cAMP induction of 3/~HSD mRNA can be observed only when aminoglutethimide (AG), an inhibitor of cholesterol metabolism, is added to the Leydig cell cultures. The addition of AG also markedly increases cAMP induction of CYP17 mRNA levels. Addition of testosterone or the androgen agonist, mibolerone, to cAMP plus AG treated cultures reduced 3~HSD and CYP17 mRNA levels to levels comparable to those observed when cells were treated with cAMP only. These data indicate that testosterone acting via the androgen receptor represses expression of both CYPI7 and 3~HSD. The role of protein synthesis in mediating the cAMP induction of 3~HSD, CYPI7 and CYPI1A was examined. The addition of cycloheximide, an inhibitor of protein synthesis, to cAMP treated cultures for 24 h completely suppressed both constitutive and cAMP-induced 3~HSD mRNA levels. Cycloheximide also repressed cAMP-induced levels of CYPI7 to 12% of levels observed in the absence of cycloheximide. In sharp contrast, treatment for 24 h with cycloheximide did not suppress cAMP induction of CYP1 IA mRNA, but reduced basal levels by approx. 50%. These data indicate that newly synthesized protein(s) are required for cAMP induction of CYPI7 and 3]~HSD mRNA levels, but not for CYP11A mRNA.
INTRODUCTION
Biosynthesis of testosterone from cholesterol in Leydig cells involves the action of four enzymes (Fig. 1) . The initial rate-limiting step in this pathway is the conversion of the C27 steroid, cholesterol, to the C:, steroid, pregnenolone, which is catalyzed by the cytochrome P450 enzyme, cholesterol side-chain cleavage
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(CYPllA). This enzyme is located in the inner mitochondrial membrane. Pregnenolone diffuses across the mitochondrial membrane and is further metabolized by enzymes associated with the smooth endoplasmic reticulum. In the mouse Leydig cell, pregnenolone is first converted to progesterone by the action of 3fl-hydroxysteroid dehydrogenase/A 5-> A 4-isomerase (3flHSD). The next reaction is catalyzed by the cytochrome P450 enzyme, CYP17. CYP17 catalyzes two reactions, 17~-hydroxylation of progesterone followed by cleavage of the C~7-20 bond to yield the C~9 steroid, androstenedione, the immediate precursor of testosterone. The final reaction in the bio- synthesis of testosterone is the reduction of the 17 ketone of androstenedione by 17 ketosteroid reductase (17KSR).
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This paper will focus on the regulation of expression of CYP11A, CYP17 and 3flHSD in mouse Leydig cell cultures by cyclic AMP (cAMP) and steroids as well as their tissue specific expression. Identification of a cAMPresponsive region in the mouse Cyp! 7 gene and repression of cAMP-induced expression of Cypl 7 by the mouse androgen receptor will be discussed as well as the identification of Leydig cell-specific sequences in the mouse Cyplla gene. A review by Waterman et al. [1] as part of this symposium issue summarizes unique cAMP-responsive sequences (CRS) in the bovine CYP17 and CYPllA genes and in the human CYP21B gene [1] .
REGULATION OF CYPIIA, CYPI7 AND 3.~HSD EXPRESSION IN MOUSE LEYDIG CELLS
Earlier studies from our laboratory demonstrated that in mouse Leydig cell cultures cAMP is essential for de novo synthesis of CYPI7, but not for CYP11A. In the absence of cAMP, de novo synthesis of CYP 17 ceases, while CYP 11A exhibits high basal synthesis [2] . We have also shown that steroid hormones negatively regulate de novo synthesis of CYP17 [3] and Fig. 3 . Effect of cAMP and dexamethasone on P450scc synthesis and mRNA levels in mouse Leydig cells. Cultures were treated for 6 days before the initiation of treatment for 24h with 0.1 tiM dexamethasone (Dex) or 50/tM 8-BrcAMP (cAMP) and P450scc synthesis and mRNA levels were quantitated in parallel in three separate experiments. P450scc de novo synthesis was measured as described in Fig.  2 and mRNA was quantitated by dot blot hybridization.
CON, nontreated controls. From Hales and Payne [4] .
CYP11A [4] in normal mouse Leydig cells. The repression is specific for a particular steroid hormone and for the enzyme. Glucocorticoids repress both basal and cAMP-stimulated CYP11A protein synthesis and mRNA levels as shown in Figs 2 and 3 [4] , while testosterone represses cAMP-induced synthesis of CYP17 [2] . The repression by these steroids can be prevented by the appropriate steroid antagonist. RU486 prevents the repression caused by dexamethasone [4] while hydroxyflutamide prevents the repression caused by testosterone [3] . These findings indicate that the repression caused by these steroid hormones is mediated via their respective steroid receptors. Estradiol has no effect on the synthesis of CYPllA (Fig. 2) or CYP1713,4]. In contrast to our finding in normal Leydig cells, the glucocorticoid, dexamethasone, stimulates both de novo synthesis and steady state levels of CYPllA mRNA in MA-10 tumor Leydig cells [5] . The stimulatory effect of dexamethasone in MA-10 cells is additive to the stimulatory effect of cAMP [5] . Although glucocorticoids are not produced in Leydig cells, glucocorticoid receptors have been demonstrated in interstitial cells of the rat testis [6] . Increased production of glucocorticoids in pathologic conditions of the adrenal cortex, such as Cushing's syndrome can be associated with reproductive dysfunction, including decreased circulating testosterone [7] . The studies from our laboratory have identified two sites in the biosynthetic pathway from cholesterol to testosterone, CYPllA and 3flHSD, where increased circulating concentrations of glucocorticoids could act to decrease testicular testosterone production [4, 8] .
In more recent studies we have investigated cAMP induction and steroid repression of Fig. 5 . Effects of mibolerone, dexamethasone, and estradiol on 3flHSD and CYP17 (P45017~) mRNA levels. Mouse Leydig cells were incubated and treated as described in Fig. 4 . Mibolerone (Mib; 2/~M), dexameth~one (Dex; 100 nM), estradioi (E2; 100 nM), and (E2*; 1 #M) were added to cAMP-plus aminoglutethimide (AG)-treated cultures where indicated. Total cytoplasmic RNA was isolated and 7 #g were subjected to Northern analysis and hybridized, as described in Fig. 4 . From Payne and Sha [8] .
CYP17 and 3flHSD mRNA levels in mouse Leydig cell cultures. Purified mouse Leydig cells are incubated in a serum-free medium containing 0.1% bovine serum albumin and 500 gg/ml insulin. Cultures are maintained for 6 days prior to treatment. Figure 4 illustrates that in the absence of treatment with cAMP, CYP17 mRNA levels are undetectable while 3flHSD mRNA is expressed at high basal levels, similar to what is found with CYP11A mRNA (Fig. 3) . Treatment of Leydig cell cultures for 24 h with increasing concentrations of cAMP (50-500 g M) markedly decreases the levels of 3flHSD mRNA relative to that of untreated control cultures while CYP17 mRNA levels are induced [8] . The addition of aminoglutethimide, an inhibitor of cholesterol metabolism, together with cAMP results in marked increases in both CYP17 and 3flHSD mRNA levels relative to untreated control cultures or to cultures treated only with cAMP (Fig. 4) . This observation suggests that testosterone, which is produced in high amounts during treatment of normal mouse Leydig cell cultures with cAMP, represses the cAMP induction of both 3flHSD and CYP17 mRNA's [8] . 6 ) and cAMP-induced levels of 3flHSD mRNA, but not of CYP17 mRNA ( Fig. 5 and Ref. [8] ). The requirement for newly synthesized proteins in mediating cAMP induction of CYP17 and 3flHSD differs from that of CYP11A (Fig.  6 ). Inhibition of protein synthesis for 24 h by the addition of cyclobeximide to Leydig cell cultures 30m in before treatment completely suppressed both basal and cAMP-induced expression of 3flHSD mRNA. Cycloheximide also markedly suppressed the cAMP induction of CYP17 mRNA. In contrast, the same treatment with cycloheximide did not suppress cAMP induction of CYPI 1A mRNA, however, basal expression was reduced.
The role of protein synthesis and the time required for maximal cAMP induction of CYP17 and CYPllA mRNA was investigated in greater detail [5] . Determination of cAMPstimulated mRNA levels of CYP17 and CYP11A in the same Leydig cell cultures at 6, 12 and 24h following treatment with cAMP in the presence or absence of cycloheximide resulted in the following observations: (1) cAMP induction of CYPIlA mRNA is slow, with the greatest increase over basal levels occurring between 12 and 24h; (2) cAMPinduced increases in CYPllA mRNA at 12 and 24 h were not prevented by the addition of cycloheximide, while basal expression was reduced approx. 50%; (3) the temporal pattern of cAMP induction of CYP17 was very similar to that of CYPI1A, a marked increase in CYP17 mRNA levels was observed between 12 and 24 h; (4) inhibition of protein synthesis markedly suppressed cAMP induction of CYP17 at all time intervals examined [8] . These data indicate that newly synthesized proteins are required for cAMP induction of CYP17 and 3flHSD mRNA levels, but not for CYPllA mRNA. Furthermore, maximal induction by cAMP of CYP17 and CYPllA mRNA takes several hours. This type of response is characteristic of genes whose induction by cAMP is mediated by newly synthesized proteins [9] . The results with cycloheximide, however, indicate that cAMPinduced increases in CYPllA mRNA do not require newly synthesized proteins. These findings indicate that cAMP-induced increases in these two P450 mRNA's in normal mouse Leydig cells occur by a different mechanism(s).
The role of protein synthesis in mediating cAMP induction of CYP17 and CYPllA has been studied in a variety of steroidogenic cells from different species. The results appear to be dependent on the cell type and experimental conditions. John et al. [10] and Zuber et al. [11] reported that in cultures of bovine adrenocortical cells cycloheximide prevented the cAMP induction of CYPllA and CYP17 mRNA. These results indicate that in bovine adrenal cells newly synthesized proteins are required for the cAMP induction of both CYP17 and CYPllA mRNA. More recently, however, the same laboratory studied chimeric reporter gene constructs containing the 5' cAMP responsive sequences of either bovine CYPIIA or CYPI7 transiently transfected into bovine adrenocortical cells or Y-1 mouse adrenal tumor cells [12, 13] . Inhibition of protein synthesis by cycloheximide did not reduce cAMP-induced expression of these transiently transfected reporter genes containing either CYPIIA or CYP17 sequences. The reason for the discrepancy of the effect of cycloheximide on the expression of endogenous bovine genes and that of reporter genes is not obvious at this time.
Other reports on the role of newly synthesized proteins in mediating cAMP induction of . Effect of inhibition of protein synthesis on the expression of 3flHSD, CYP17 (P45017~) and CYP11A (P450scc) mRNA. Leydig cells were incubated and treated as described in Fig. 4 . Cycloheximide (CHX; 10 #g/ml) was added 30rain before addition of 50 #M cAMP (cA) or 100 nM dexamethasone (Dex). CHX was added to untreated control cultures (Con) at the same time as it was added to the other cultures. After 24h, total RNA was isolated and subjected to Northern analysis and hybridized sequentially with 3flHSD, Cypl7, Cyplla and fl-actin eDNA probes. From Payne and Sha [8] . CYPllA mRNA do not show a consistent pattern. Cycloheximide inhibition of cAMPstimulated increases in CYP11A mRNA was reported in the transformed human trophoblastic cell line JEG-3 [14] , but was not observed for CYPllA in cultures of human granulosa cells [15] . We previously reported that cAMP-and dexamethasone-induced increases in CYPllA mRNA are blocked by cycloheximide in MA-10 tumor Leydig cells in contrast to normal mouse Leydig cells [16] . No effect of cycloheximide was observed on basal levels of CYPllA mRNA. In contrast to our results in MA-10 cells, Mellon and Vaise [17] reported that cycloheximide does not inhibit cAMP-stimulated increases in CYPllA mRNA in this Leydig cell line, but decreases basal CYPllA mRNA levels. The differences in the two studies are probably due to differences in the time cells were exposed to cycloheximide, since in normal Leydig cells we observed an effect of cycloheximide on cAMP induction of CYPllA mRNA at 6h but not after 12 or 24 h of treatment [8] . The role of newly synthesized protein mediators in cAMP-induced transcription of the genes encoding CYP11A and CYP17 requires further investigation. were isolated and characterized [18] . To identify sequences involved in the cAMP regulation of mouse CypI 7 and to investigate further the mechanism by which cAMP induces transcription of Cypl7, fragments 5' of the coding region were subcloned into vectors containing the chloramphenicol acetyl transferase (CAT) reporter gene [18] . Constructs containing different lengths ~ of 5' upstream sequences up to 4.5 kb were transiently transfected into MA-10 tumor Leydig cells and treated with cAMP. MA-10 tumor Leydig cells do not express endogenous CYP17 mRNA as shown in Fig. 7 , and thus produce progesterone rather than testosterone when stimulated with human chorionic gonadotropin [19] or with cAMP [5] . cAMP response of the constructs was determined by measuring CAT activity (amount of chloramphenicol acetylated with [3H]acetate) in the cell extracts. hypothesis that the mouse Cypl7 gene belongs to the class of cAMP-responsive genes that require a newly synthesized protein(s) and that cAMP-induced increases are probably not mediated by the ubiquitous CRE-binding protein (CREB) [9] . To further define sequences essential for cAMP induction, additional deletions of the l.l kb 5' flanking construct were made. The results of those studies are shown in Fig. 10 . Very low expression is seen in the construct containing -245 bp, with a marked increase seen in the construct containing up to -346 bp. This construct also shows a small increase in basal expression. There appears to be a further increase in cAMP-induced expression in the constructs containing between -435 and -1021 bp. These data indicate that the cAMPresponsive region is between -245 and -346 with possibly additional enhancement of the cAMP-induced expression by sequences found between -435 and -1021 bp.
When the sequence of the mouse Cypl7 cAMP-responsive region (-245/-346) is aligned to the cAMP-responsive sequences of the human [20] and bovine [21] genes, no apparent homology was observed among these three CYP17cAMP-responsive regions [18] . Previous studies by Brentano et al. [22] on human Previous studies from our laboratory demonstrated that testosterone or the androgen agonist mibolerone repressed cAMP induction of CYP17 protein synthesis [3] and mRNA levels [8] in normal mouse Leydig cells. The repression of cAMP-induced increases by testosterone could be prevented by the androgen antagonist, hydroxyflutamide [3] . These data indicated that endogenous testosterone produced during cAMP induction of CYP17 negatively regulates the rate of CYP17 protein synthesis and mRNA levels by an androgen receptor-mediated mechanism [3, 8] . To investigate whether this repression of cAMP-induced CYP17 protein synthesis and mRNA levels by an androgen receptor-mediated mechanism occurred at the level of transcription, experiments were carried out using the Cypl7-CAT construct containing 4.5kb of 5' flanking This construct has been shown to interact with the mouse androgen receptor and its expression is dependent on androgen. Treatment of MA-10 cells transfected with the 3 x (HRE)tkCAT plasmid with the androgen dihydrotestosterone (DHT) did not increase CAT activity suggesting that MA-10 cells do not contain endogenous androgen receptor (Fig. 11) . We therefore cotransfected the MA-10 cells with a mouse androgen receptor (mAR) expression vector [24] . Cotransfection of the 3 x (HRE)tkCAT with the mAR expression vector followed 18 h later by treatment with DHT for 12 h resulted in a 3-to 4-fold increase in CAT activity (Fig. 11) . DHT treatment of cells cotransfected with the mAR and with the tkCAT reporter gene lacking the 3 x (HRE) did not result in an increase in CAT activity.
To examine the effect of androgens on cAMPinduced expression of Cypl 7-CAT, MA-10 cells were cotransfected with the 4.5 kb Cypl7-CAT construct (5 #g) and with increasing amounts of the mAR (0-4#g) and treated for 12h with cAMP or cAMP plus DHT. Figure 12 illustrates that increasing amounts of mAR caused a dosedependent repression of cAMP-induced Cyp 17-CAT expression in the absence of DHT. The addition of DHT resulted only in a small further decrease in CAT activity of ~ 25%. No effect of DHT was observed in the absence of cotransfected mAR. The observed dose-dependent decrease in cAMP-induction of Cyp17-CAT expression with increasing amounts of mAR alone and the small additional decrease observed with the addition of DHT suggest that cAMP has the capacity to activate the androgen receptor. To test this hypothesis, the 3 x (HRE)tkCAT construct was cotransfected with 4 #g mAR into MA-10 cells and cells were treated with 500#M cAMP, 2#M DHT or cAMP plus DHT. Treatment with cAMP resulted in a similar increase in the 3 x (HRE)tkCAT expression as was observed when cells were treated with DHT only. Treatment with cAMP plus DHT resulted in essentially the same amount of induction as with either compound alone (Fig. 13) . These data suggest that cAMP as well as DHT can activate the mAR. Furthermore, these data suggest that activation of the androgen receptor involves phosphorylation of the receptor. This suggestion is supported by a report by van Laar et al. [25] that steroid hormone-induced phosphorylation of the human androgen receptor was accompanied by transformation of the receptor protein to a tight nuclear binding form. Thus, our observations in the present study and the report by van Laar et al. are consistent with the proposal that activation of the androgen receptor involves phosphorylation. Denner et al. [26] reported similar findings of cAMP or progesterone activation of the chicken progesterone receptor as we observed with the mAR. These authors showed that progesterone receptor-mediated transcription of a target gene, in transiently transfectcd CV1 cells, was increased by treatment of cells with 8-Br-cAMP in the absence of the steroid ligand, progesterone. This finding indicates that the chicken progesterone receptor as well as the mAR can be activated by cAMP as well as by their respective steroid ligands. Future studies should determine whether cAMP activation of steroid receptors is an alternate mechanism for activating all steroid receptors or whether cAMP activation is specific for certain steroid receptors.
Data presented in this section indicate that the androgen receptor-mediated repression of CYP17 protein synthesis and mRNA levels observed in mouse Leydig cells reflects an inter- 
LEYDIG CELL SPECIFIC SEQUENCES FOR THE EXPRESSION OF MOUSE Cyplla
In a recent study on the analysis of the promoter region of the gone encoding mouse Cyplla, it was found that constructs containing 1500 bp of 5' flanking region, when transfected into mouse Y-I adrenocortical cells, exhibited high levels of expression of a growth hormone reporter gone [27] . In contrast, the same construct showed very low expression in mouse MA-10 Leydig cells. To examine whether additional sequences are necessary for the ex- CAT activity is expressed relative to the promoterless pGSVOCAT plasmid.
the mouse [28] . 
CONCLUSIONS
This chapter reviews the complexity of the regulation of expression of the enzymes involved in testosterone production in Leydig cells. The three major enzymes studied, CYP11A, CYP17 and 3~HSD are differentially regulated. Maximal levels of mRNA for the three enzymes requires cAMP. There is high basal expression of both CYP11A and 3/~HSD mRNA, while expression of CYP17 mRNA is absolutely dependent on chronic stimulation by cAMP. Endogenously produced testosterone in normal mouse Leydig cells acting via the androgen receptor negatively regulates expression of cAMP-induced CYP17 as well as 3~HSD mRNA, while glucocorticoids acting via the glucocorticoid receptor repress CYPllA and 3f/HSD mRNA levels. The mechanism by which cAMP increases expression of the three enzymes in normal mouse Leydig cells is different. Newly synthesized proteins are essential for cAMP induction of CYPI7 and 3/~HSD mRNA, but not for CYPIlA mRNA. In the absence of protein synthesis for a 24 h period, basal levels of 3//HSD mRNA are completely repressed while basal levels of CYP11A mRNA are reduced by 50% indicating that rapidly turning over proteins are required for basal expression of 3//HSD and CYPllA mRNA.
Data are presented identifying the cAMPresponsive region in the 5' flanking sequences of mouse CyplZ Constructs containing different length fragments of the Cyp 17 5' flanking region fused to the CAT reporter gene were transfected into MA-10 tumor Leydig cells, and sequences between -245 and -346 were identified as the cAMP-responsive region. We demonstrate that 12 h are required for cAMP to maximally increase CypI7-CAT expression and that no increase in expression is observed at 2 h with only a small increase at 4 h. This observation is consistent with the results observed in normal mouse Leydig cells that cAMP induction of CYP17 mRNA requires newly synthesized proteins. Furthermore, we demonstrate that repression by the androgen receptor of cAMP induction of Cypl7occurs at the level of transcription. In addition, data are presented that indicate that the mAR can be activated by cAMP in the absence of the androgen ligand. This observation provides evidence for a novel mechanism of steroid receptor activation which may lead to new theories about the transformation of steroid receptors from an inactive form to an active DNA-binding form.
Evidence is presented for the presence of specific sequences in the 5' flanking region of the Cyplla structural gene that are required for Leydig cell expression. These data indicate that there are tissue-specific factors that are necessary for expression of CYP11A in Leydig cells and in adrenal glands.
